Market Research Report
2016 IRBESARTAN (CAS 138402-11-6) INDUSTRY REPORT - GLOBAL AND CHINESE MARKET SCENARIO
Indian and Chinese pharmaceutical companies get approval to carry out marketing of products in U.S. market Hypertension and high blood pressure are one of the most common problems faced by individuals worldwide. A competitive environment at any stage in life contributes to this issue which needs to be addressed at the right time. As the number of people suffering from this acute problem has increased, the demand for drugs and medicines that help in curing this problem has also increased. Irbesartan is used for the treatment of hypertension and high blood pressure. A report added by the Prof Research team gives valuable insights such as the market share, size, and value related to the Irbesartan industry. Treatment of high blood pressure is very important as it may lead to bleeding stroke if untreated at the right time. “It is important to be aware of having high blood pressure in the first place, and once diagnosed, to have it treated appropriately� said Dr Kyle Walsh, study author in an American Stroke Association news release. It is very important to use the substance as per the amount recommended and prescribed to avoid any negative effects on consumption. Unichem Laboratories and Zhejiang Hisun Pharmaceutical Co. Ltd enter U.S markets after USFDA approval
Request For Sample Report @ http://www.profresearchreports.com/request-sample/16389
It is a known fact that it is not easy for any pharmaceutical company to get the approval from the food and drug administrations to market Irbesartan in a particular market or region. The required standards have to be met and followed. This is mainly to avoid unregulated use of the substance that possesses harmful side effects that may come along with it. In December 2015, Unichem Laboratories was given a final approval from the US health regulator to market and promote Irbesartan tablets in the American markets. The approval came from the US Food and Drug Administration (USFDA). The tablets more or less have the same properties that are found in Sanofi-aventis’s Avapro tablets. “The product would be commercialized from Unichem’s Ghaziabad plant. Active Pharmaceutical Ingredient (API) for the product would also be made in house at Pithampur plant” said a company spokesperson. You Can Buy Report Easily Here @ http://www.profresearchreports.com/request-sample/16389
Chapter One Introduction of Irbesartan Industry 1.1 Brief Introduction of Irbesartan 1.2 Development of Irbesartan Industry 1.3 Status of Irbesartan Industry Chapter Two Manufacturing Technology of Irbesartan 2.1 Development of Irbesartan Manufacturing Technology 2.2 Analysis of Irbesartan Manufacturing Technology 2.3 Trends of Irbesartan Manufacturing Technology Chapter Three Analysis of Global Key Manufacturers (Including Company Profile, Product Specification, 2010-2015 Production Information etc.) 3.1 Company A 3.2 Company B 3.3 Company C …………
Chapter Four 2011-2016 Global and Chinese Market of Irbesartan 4.1 2011-2016 Global Capacity, Production and Production Value of Irbesartan Industry 4.2 2011-2016 Global Cost and Profit of Irbesartan Industry 4.3 Market Comparison of Global and Chinese Irbesartan Industry 4.4 2011-2016 Global and Chinese Supply and Consumption of Irbesartan 4.5 2011-2016 Chinese Import and Export of Irbesartan Chapter Five Market Status of Irbesartan Industry 5.1 Market Competition of Irbesartan Industry by Company 5.2 Market Competition of Irbesartan Industry by Country (USA, EU, Japan, Chinese etc.) 5.3 Market Analysis of Irbesartan Consumption by Application/Type Chapter Six 2016-2021 Market Forecast of Global and Chinese Irbesartan Industry 6.1 2016-2021 Global and Chinese Capacity, Production, and Production Value of Irbesartan 6.2 2016-2021 Irbesartan Industry Cost and Profit Estimation 6.3 2016-2021 Global and Chinese Market Share of Irbesartan 6.4 2016-2021 Global and Chinese Supply and Consumption of Irbesartan 6.5 2016-2021 Chinese Import and Export of Irbesartan
“Probably you are looking for our Executive summary� Visit Here http://www.profresearchreports.com/irbesartan-cas-138402-11-6industry-2016-global-and-chinese-analysis-market Stay With US
Global Head Quarters 5320 SW Macadam Avenue, Suite 100, Portland, OR 97239, United States.
E-mail : help@profresearchreports.com
Telephone Direct : +1 (617) 674-4143 Toll Free : +1 (855) 711-1555 Fax : +1 (855) 550-5975